Expression and Subcellular Localization of the Cyclin-Dependent Kinase Inhibitor p27 Kip1 in Epithelial Ovarian Cancer

Author： Hurteau J.A.   Allison B.M.   Brutkiewicz S.A.   Goebl M.G.   Heilman D.K.   Bigsby R.M.   Harrington M.A.  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.83, Iss.2, 2001-11, pp. : 292-298

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 (Kip1) in estrogen-related endometrial adenocarcinomas

By Torricelli Michela   Sanseverino Francesca  

The Women's Oncology Review, Vol. 4, Iss. 1, 2004-01 ,pp. : 19-20

Informa Healthcare

Access to resources Recommend Favorite

Overexpression of a Stabilized Mutant Form of the Cyclin-Dependent Kinase Inhibitor p27Kip1 Inhibits Cell Growth

By Hurteau J.A.   Brutkiewicz S.A.   Wang Q.   Allison B.M.   Goebl M.G.   Harrington M.A.  

Gynecologic Oncology, Vol. 86, Iss. 1, 2002-07 ,pp. : 19-23

Academic Press

Access to resources Recommend Favorite

The Concurrent Expression of p27 kip1 and Cyclin D1 in Epithelial Ovarian Tumors

By Sui L.   Tokuda M.   Ohno M.   Hatase O.   Hando T.  

Gynecologic Oncology, Vol. 73, Iss. 2, 1999-05 ,pp. : 202-209

Elsevier

Access to resources Recommend Favorite

Implication of Malignancy and Prognosis of p27 kip1 , Cyclin E, and Cdk2 Expression in Epithelial Ovarian Tumors

By Sui L.   Dong Y.   Ohno M.   Sugimoto K.   Tai Y.   Hando T.   Tokuda M.  

Gynecologic Oncology, Vol. 83, Iss. 1, 2001-10 ,pp. : 56-63

Elsevier

Access to resources Recommend Favorite

Cyclin-dependent kinase inhibitor p27 as a prognostic biomarker and potential cancer therapeutic target

By Hershko Dan D  

Future Oncology, Vol. 6, Iss. 12, 2010-12 ,pp. : 1837-1847

Future Medicine

Access to resources Recommend Favorite